COMMON STOCK PURCHASE WARRANT RESTORGENEX CORPORATIONRestorGenex Corp • April 3rd, 2015 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Isaac Blech (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the four (4) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from RestorGenex Corporation, a Nevada corporation (the “Company”), up to 75,000 shares (the “Warrant Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).
STOCK OPTION AGREEMENTStock Option Agreement • April 3rd, 2015 • RestorGenex Corp • Pharmaceutical preparations • Nevada
This STOCK OPTION AGREEMENT (this “Agreement”) is made and entered into effective as of by and between RestorGenex Corporation, a Nevada corporation (the “Company”), and (“Optionee”) with reference to the following facts:
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 3rd, 2015 • RestorGenex Corp • Pharmaceutical preparations • Illinois
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of October 21, 2014 by and between RestorGenex Corporation (formerly Stratus Media Group), a Nevada corporation (the “Company”), and Isaac Blech (“Purchaser”).
April 23, 2014 Dear Mr. Rubinstein,RestorGenex Corp • April 3rd, 2015 • Pharmaceutical preparations
This letter serves as a formal agreement between RestorGenex (formerly Stratus Media Group) and yourself regarding board of director’s fees earned by you during your service as a director. This will confirm that you have agreed to accept the following sums as all amounts due and owing to you for all service as a board member and employee excluding stock and cash owed to you as director only since January 1, 2014:
